A gift to Big Pharma this week as a study appearing in Circulation Cardiovascular Quality Outcomes appears to show that the introduction of generic drugs is associated with a spike in adverse events. For the video version, click here.
Read MoreA study appearing in the Annals of Internal Medicine sheds light on why prices of generic drugs have been increasing recently. For the video version, click here.
Read MoreSignificant barriers are placed between pharmaceutical companies and physicians to avoid conflict-of-interest. But do strict policies preventing pharmaceutical marketing to physicians actually limit prescriptions? For the video version, click here.
Read More
